Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• Váldodahkkit: Rachel S Laufer (Dahkki), Ranju Baral (Dahkki), Andrea G Buchwald (Dahkki), James D Campbell (Dahkki), Flanon Coulibaly (Dahkki), Fatoumata Diallo (Dahkki), Moussa Doumbia (Dahkki), Amanda J Driscoll (Dahkki), Alison P Galvani (Dahkki), Adama M Keita (Dahkki), Kathleen M Neuzil (Dahkki), Samba Sow (Dahkki), Clint Pecenka (Dahkki), Justin R Ortiz (Dahkki), Meagan C Fitzpatrick (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...